Bulevirtide
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Bulevirtide, covering 2024-07-29 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide [Phase 2, Phase 3]